Fondazione Toscana Gabriele Monasterio

Address
Via Giuseppe Moruzzi 1

Sponsor Overview

assignment
4
sponsored trials
science
5
molecules
location_city
22
research centres
public
1
country
person_search
26
investigators

Specializations

Cardiac amyloidosis imaging and diagnosis

Research activity centres on ATTR cardiac amyloidosis and AL cardiac amyloidosis, with a strong focus on PET/CT approaches for identifying cardiac amyloid deposits and distinguishing diagnostic pathways.

  • 18F-flutemetamol tracer evaluation
  • 18F-florbetaben PET/CT diagnostic assessment
  • Non-invasive diagnosis of AL-CA

The sponsor’s work in this area is directed toward improving the recognition of amyloid involvement in the heart and supporting clearer diagnostic classification across inherited and wild-type disease.

Transthyretin amyloid cardiomyopathy

Another key area is ATTR-CA, including studies that examine functional status and symptom burden in people living with transthyretin-related cardiac disease.

  • Exercise capacity
  • Quality of life
  • Cardiac functional impairment

These investigations reflect interest in the clinical impact of amyloid cardiomyopathy beyond diagnosis, with attention to patient-centred outcomes in chronic heart disease.

Atrial fibrillation and left atrial appendage closure

The sponsor also supports research in atrial fibrillation management, particularly in patients undergoing percutaneous left atrial appendage closure with the Amulet device.

  • Antiplatelet therapy
  • Thrombotic complications
  • Bleeding events

This area focuses on post-procedural cardiovascular care and the balance between protection from thromboembolic risk and avoidance of bleeding harm.

Cardiovascular therapeutics in amyloid heart disease

Clinical interests extend to treatment strategies for amyloid-related heart disease, including therapies used to address symptoms and functional limitation in cardiac amyloidosis.

  • Dapagliflozin
  • Cardiovascular symptom management
  • Functional capacity improvement

The sponsor’s funded studies place emphasis on therapeutic options relevant to patients with progressive infiltrative cardiomyopathy and associated exercise intolerance.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 5 total (0% not shared with other sponsors)

This sponsor works with 5 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
9%
Return partnership rate
2 of 22 sites collaborated multiple times

This sponsor has worked with 22 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Cardiovascular Diseases4 trials
    359 other sponsors

Partnered Research Centres

22 centres
location_city
assignment413
ASST Grande Ospedale Metropolitano Niguarda
Address
Piazza Dell'ospedale Maggiore 3, 20162 Milan
Learn morearrow_forward
location_city
assignment147
Azienda Ospedaliera Ordine Mauriziano Di Torino
Address
Via Ferdinando Magellano 1, 10128 Turin
Learn morearrow_forward
location_city
assignment338
Azienda Ospedaliera Papa Giovanni XXIII
Address
Piazza Oms 1, 24127 Bergamo
Learn morearrow_forward
location_city
assignment560
Azienda Ospedaliera Universitaria Federico II Di Napoli
Address
Via Sergio Pansini 5, 80131 Naples
Learn morearrow_forward
location_city
assignment624
Azienda Ospedaliero Universitaria Careggi
Address
Largo Giovanni Alessandro Brambilla 3, 50134 Florence
Learn morearrow_forward
location_city
assignment118
Azienda Ospedaliero Universitaria Di Sassari
Address
Via Michele Coppino 26, 12100 Sassari
Learn morearrow_forward
Page 1 of 4

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Fondazione Toscana Gabriele Monasterio.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.